Active Surveillance for Cancer of the Prostate (ASCaP)

Part of paid clinical trials in Los Angeles, California.

Sponsor
Jonsson Comprehensive Cancer Center
Study ID
NCT00949819
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
MALE
Age
30 Years - 85 Years
Healthy Volunteers
Not accepted

Interventions

  • Active surveillance — OTHER
    Serial, long term data collection and active surveillance

Study Details

Active Surveillance (A.S.) of prostate cancer (CaP) is the systematic monitoring of men with low-risk, localized lesions, with curative treatment of those whose tumors show substantial progression. A.S. is different from Watchful Waiting (W.W.), which is the palliative treatment of men with progressive prostate cancer.

Key Dates

Start date
Jul 4, 2009
Status verified
May 2026
Primary completion
Jul 5, 2027
Completion
Dec 31, 2028

Study Design

Enrollment
462 participants (estimated)

Arms

  • Arm: no treatment
    Men with previously untreated, early stage prostate cancer.

Primary Outcome Measure

Discover and confirm clinical parameters that predict aggressive disease as defined by pre-specified histological, PSA, clinical criteria, or outcomes based on these variables. [ Time Frame: Interim data analysis will be made every year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of California Los AngelesLos AngelesCalifornia90095
Leonard S Marks, M.D. (PRINCIPAL_INVESTIGATOR)

Find similar trials in Los Angeles, CA

By condition
Prostate cancer
By specialty
OncologyProstate oncologyMen's healthUrology
By research site
University of California Los Angeles· Los Angeles, CA

Related Studies